[PHARMA] YoY TTM Result on 31-Mar-2019 [#1]

Announcement Date
16-May-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Mar-2019 [#1]
Profit Trend
QoQ- 4.78%
YoY- -15.06%
Quarter Report
View:
Show?
TTM Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 4,983,690 2,698,649 2,854,343 2,553,141 2,323,589 2,248,121 2,276,603 13.94%
PBT 282,990 36,437 -191,228 71,756 73,994 73,256 100,648 18.79%
Tax -104,757 -9,755 44,548 -26,467 -20,676 -26,609 -29,520 23.49%
NP 178,233 26,682 -146,680 45,289 53,318 46,647 71,128 16.53%
-
NP to SH 176,748 28,226 -146,437 44,499 52,386 46,143 70,629 16.51%
-
Tax Rate 37.02% 26.77% - 36.88% 27.94% 36.32% 29.33% -
Total Cost 4,805,457 2,671,967 3,001,023 2,507,852 2,270,271 2,201,474 2,205,475 13.85%
-
Net Worth 413,947 355,919 350,047 528,825 524,838 544,360 515,906 -3.60%
Dividend
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Div 121,759 23,534 22,188 44,226 51,913 41,456 69,935 9.67%
Div Payout % 68.89% 83.38% 0.00% 99.39% 99.10% 89.84% 99.02% -
Equity
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Net Worth 413,947 355,919 350,047 528,825 524,838 544,360 515,906 -3.60%
NOSH 1,309,126 261,705 261,229 260,505 259,821 259,219 258,859 30.99%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 3.58% 0.99% -5.14% 1.77% 2.29% 2.07% 3.12% -
ROE 42.70% 7.93% -41.83% 8.41% 9.98% 8.48% 13.69% -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
RPS 380.45 1,031.18 1,092.66 980.07 894.30 867.27 879.48 -13.02%
EPS 13.49 10.79 -56.06 17.08 20.16 17.80 27.28 -11.06%
DPS 9.30 9.00 8.50 17.00 20.00 16.00 27.00 -16.26%
NAPS 0.316 1.36 1.34 2.03 2.02 2.10 1.993 -26.42%
Adjusted Per Share Value based on latest NOSH - 260,505
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
RPS 345.79 187.24 198.05 177.15 161.22 155.98 157.96 13.94%
EPS 12.26 1.96 -10.16 3.09 3.63 3.20 4.90 16.50%
DPS 8.45 1.63 1.54 3.07 3.60 2.88 4.85 9.69%
NAPS 0.2872 0.247 0.2429 0.3669 0.3642 0.3777 0.358 -3.60%
Price Multiplier on Financial Quarter End Date
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Date 31/03/22 31/03/21 31/03/20 29/03/19 30/03/18 31/03/17 31/03/16 -
Price 0.755 3.26 1.26 2.27 4.28 4.89 5.76 -
P/RPS 0.20 0.32 0.12 0.23 0.48 0.56 0.65 -17.82%
P/EPS 5.60 30.23 -2.25 13.29 21.23 27.47 21.11 -19.83%
EY 17.87 3.31 -44.49 7.53 4.71 3.64 4.74 24.74%
DY 12.32 2.76 6.75 7.49 4.67 3.27 4.69 17.45%
P/NAPS 2.39 2.40 0.94 1.12 2.12 2.33 2.89 -3.11%
Price Multiplier on Announcement Date
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Date 20/05/22 21/05/21 19/05/20 16/05/19 16/05/18 16/05/17 13/05/16 -
Price 0.72 4.03 1.88 2.36 4.07 4.72 5.60 -
P/RPS 0.19 0.39 0.17 0.24 0.46 0.54 0.64 -18.31%
P/EPS 5.34 37.37 -3.35 13.82 20.19 26.52 20.52 -20.08%
EY 18.74 2.68 -29.82 7.24 4.95 3.77 4.87 25.16%
DY 12.92 2.23 4.52 7.20 4.91 3.39 4.82 17.85%
P/NAPS 2.28 2.96 1.40 1.16 2.01 2.25 2.81 -3.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment